VETRANO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 3.950
AS - Asia 2.201
EU - Europa 803
SA - Sud America 553
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 97
OC - Oceania 4
Totale 7.720
Nazione #
US - Stati Uniti d'America 3.846
SG - Singapore 1.286
BR - Brasile 466
CN - Cina 413
VN - Vietnam 220
IT - Italia 199
FI - Finlandia 158
DE - Germania 97
IE - Irlanda 79
NG - Nigeria 69
HK - Hong Kong 60
FR - Francia 58
IN - India 58
CA - Canada 56
GB - Regno Unito 39
SE - Svezia 38
NL - Olanda 34
AR - Argentina 32
MX - Messico 25
BD - Bangladesh 22
EC - Ecuador 19
ID - Indonesia 18
RU - Federazione Russa 16
TR - Turchia 16
IQ - Iraq 14
JP - Giappone 14
ZA - Sudafrica 14
BE - Belgio 13
ES - Italia 11
IL - Israele 11
PL - Polonia 10
PH - Filippine 8
PK - Pakistan 8
PY - Paraguay 8
SA - Arabia Saudita 8
UA - Ucraina 8
MA - Marocco 7
CO - Colombia 6
EG - Egitto 6
VE - Venezuela 6
CL - Cile 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
LT - Lituania 5
RO - Romania 5
UY - Uruguay 5
UZ - Uzbekistan 5
CR - Costa Rica 4
DK - Danimarca 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
MY - Malesia 4
TN - Tunisia 4
AU - Australia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
NI - Nicaragua 2
OM - Oman 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CM - Camerun 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 7.622
Città #
Singapore 636
Wilmington 430
Chandler 388
Ashburn 304
Dallas 212
The Dalles 205
San Jose 162
Helsinki 156
San Mateo 145
Shanghai 144
Ann Arbor 128
Beijing 127
Council Bluffs 112
Boardman 96
Ho Chi Minh City 83
Leawood 81
New York 80
Dublin 79
Princeton 79
Lawrence 77
Benin City 68
Milan 66
Hanoi 58
Hong Kong 56
Paris 52
Santa Clara 48
Los Angeles 44
Fairfield 41
Woodbridge 37
São Paulo 30
Toronto 30
Amsterdam 29
Seattle 25
Phoenix 22
Abbiategrasso 21
Rome 21
Buffalo 20
Chicago 20
Columbus 20
Naples 19
London 16
Pune 16
Rio de Janeiro 15
Frankfurt am Main 14
Brussels 13
Charlotte 13
San Francisco 13
Assago 12
Munich 12
Orem 12
Belo Horizonte 11
Brooklyn 11
Curitiba 11
Da Nang 11
Mexico City 11
Las Vegas 10
Norwalk 10
Warsaw 10
Atlanta 9
Chennai 9
Houston 9
Porto Alegre 9
Boston 8
Brasília 8
Falkenstein 8
Denver 7
Johannesburg 7
Philadelphia 7
San Diego 7
Tokyo 7
Campinas 6
Guayaquil 6
Kocaeli 6
Miami 6
Montreal 6
Mumbai 6
Quito 6
Baghdad 5
Bishkek 5
Duque de Caxias 5
Fortaleza 5
Haiphong 5
Hangzhou 5
Jakarta 5
Montevideo 5
Ottawa 5
Riyadh 5
Tashkent 5
Alexandria 4
Augusta 4
Bandung 4
Ciudad del Este 4
Feira de Santana 4
Figino 4
Huntsville 4
Irvine 4
Jacksonville 4
Louisville 4
Manchester 4
Memphis 4
Totale 4.912
Nome #
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 169
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 156
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 147
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 141
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 132
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 130
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 128
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 126
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 125
Colitis-associated cancer: the dark side of inflammatory bowel disease 118
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 118
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 112
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 110
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 109
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 106
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 102
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 98
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 98
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease 97
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression 97
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 97
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 94
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 94
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. 94
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study 93
Colitis, microbiota and colon cancer: an infernal triangle 93
Antiendomysial antibody detection in fecal supernatants: In vivo proof that small bowel mucosa is the site of antiendomysial antibody production 92
OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling 91
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease 90
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 90
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer 90
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 88
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications 87
Multiple pathogenic roles of microvasculature in inflammatory bowel disease : a Jack of all trades 86
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges 86
RISK OF MICROBIAL TRANSLOCATION IN PATIENTS UNDERGOING PER-ORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA. PRELIMINARY RESULTS 85
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 85
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE 85
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 84
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? 84
Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis 84
Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11 84
Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'? 83
The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind 83
Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease 83
Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions 82
Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation 81
The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease 81
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition 80
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 80
Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6 78
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts 78
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 77
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. 77
Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies 76
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 75
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 74
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease 74
Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 74
Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus 73
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 73
Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: A multicentre study 72
GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity 72
Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients 71
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 71
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases 71
Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 70
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer 69
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE(2) pathway links innate sensing to epithelial homeostasis 68
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017 68
TNF-stimulated gene-6 (TSG-6) is a key regulator in switching stemness and biological properties of mesenchymal stem cells 67
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer 66
The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm 65
Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled trial 65
Antiendomysial Antibody Detection in Biopsy Culture Allows Avoidance of Gluten Challenge in Celiac Children 64
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer 63
Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection 61
In vitro Anti-inflammatory and Protective Effects of ibidì® on Intestinal Epithelial Cells 61
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms 59
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel 59
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 57
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis 57
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 56
Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer 53
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease 52
The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework 52
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial 50
Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? 50
Forty-Eight Hours of Biopsy Culture Improve the Sensitivity of the in Vitro Gliadin Challenge in the Diagnosis of Celiac Disease 47
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? 45
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine 42
Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors 40
Totale 7.720
Categoria #
all - tutte 47.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 3 8 77 4 2 12 54 41 38 157 32
2022/20231.103 182 65 96 118 107 85 3 76 184 104 67 16
2023/2024732 57 72 125 72 34 111 32 22 12 19 53 123
2024/20251.226 27 16 7 54 27 139 93 136 159 268 141 159
2025/20262.909 433 210 270 286 122 112 681 156 171 182 114 172
2026/2027490 279 211 0 0 0 0 0 0 0 0 0 0
Totale 7.720